October, 2022

article thumbnail

Cloud robotics labs are accelerating drug discovery and development

Pharmaceutical Technology

Drug discovery and development is an incredibly expensive and time-consuming process, taking between 12 and 18 years, and costing on average between $2 billion and $3 billion.

article thumbnail

With new startup, immunotherapy pioneer Lieping Chen tries to turn ‘cold’ tumors ‘hot’

Bio Pharma Dive

Chen, who discovered the cancer-protecting protein PD-L1, will work closely with startup Normunity to find targets that can help the immune system reach ‘cold’ tumors

Protein 275
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Actinium eyes filing as conditioning drug for AML aces trial

Pharma Phorum

Actinium Pharma is on course to submit its targeted radiotherapy for acute myeloid leukaemia (AML) patients needing a bone marrow transplant in the US, buoyed by top-line data from a pivotal trial.

article thumbnail

Dispensing Pharmacy Packaging Machines: COVID-19 Impact

Pharma Mirror

Finding a reliable supply of bar-coded, unit-dose pharmaceuticals remains difficult despite measures to improve patient safety. The ability to repackage and bar code drugs to the unit of usage is becoming increasingly necessary in health-system pharmacies. Benefits for pharmacies that invest in a high-throughput unit dose packing machine include improved productivity and management of bar-coded medicine stock.

Packaging 159
article thumbnail

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

article thumbnail

Eli Lilly receives marketing authorisation for baricitinib

Pharma Times

Treatment involves adult patients with severe alopecia areata

Marketing 138
article thumbnail

FDA Adds Additional Q&As in the Final CMC Postapproval Changes Guidance

The FDA Law Blog

By Holly N. Brevig, Senior Regulatory Device and Biologics Exper & Richard A.

More Trending

article thumbnail

CAR-T pioneer Carl June on founding biotech startups and cell therapy’s next act

Bio Pharma Dive

The University of Pennsylvania immunologist and inventor of Kymriah spoke with BioPharma Dive about working with pharma, starting companies and the future of the cell therapy field

283
283
article thumbnail

The origin- of- life patch, a key to cancer exploration

The Pharma Data

The origin- of- life patch, a key to cancer exploration. RNA, the patch that gave rise to life, has been shown to be essential for repairing mortal inheritable material and precluding mutations that might lead to developing cancer.

RNA 83
article thumbnail

Medication Management in Home Care Settings: A Brief Guide?

Pharma Mirror

Home care is an indispensable aspect of the health care system that provides individuals with long-term support and services, allowing them to remain in their homes instead of being placed in nursing facilities or hospitals.

Nurses 130
article thumbnail

Kite’s Yescarta to receive European marketing authorisation

Pharma Times

First treatment in 30 years to improve second-line treatment of DLBCL

Marketing 127
article thumbnail

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

article thumbnail

HP&M Promotes James Valentine to Director

The FDA Law Blog

By Kurt R. Karst — Hyman, Phelps & McNamara, P.C. (HP&M) HP&M) is pleased to announce that James E. Valentine will become the firm’s newest Director beginning on January 1, 2023.

article thumbnail

Lilly agrees to acquire gene therapy developer Akouos for $610m

Pharmaceutical Technology

Eli Lilly and Company has signed a definitive agreement for the acquisition of all outstanding shares of precision genetic medicine firm Akouos for a total deal value of up to nearly $610m or up to $15.50 for each share in cash. The deal comprises an acquisition value of $12.50

article thumbnail

‘In vivo’ cell therapy: expanding beyond CAR-T

Bio Pharma Dive

At least five startups have emerged with new ways to genetically modify immune cells within the body, an approach that, if successful, could widen the field of CAR-T treatment

In-Vivo 283
article thumbnail

Lilly commits $92.5 million to Purdue to establish an innovative pharmaceutical manufacturing scholarship program and to extend research collaboration

The Pharma Data

Purdue University and Eli Lilly and Company( NYSE LLY) are establishing an innovative new medicinal manufacturing education program and have renewed their strategic exploration collaboration in a series of moves that will expand their impact in Indiana and ameliorate lives on a global scale.

article thumbnail

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

article thumbnail

Artificial Intelligence (AI) in Pharma Sales and Marketing

Pharma Mirror

What is AI? Artificial intelligence (AI) is intelligence demonstrated by machines, as opposed to the natural intelligence displayed by animals including humans.

Sales 130
article thumbnail

AlzeCure gets new Alzheimer's abstract accepted

Pharma Times

Therapy is based on ACD856's indicative disease modifying effects against the condition

126
126
article thumbnail

President Biden Gives the Green Light for Significant Marijuana Reform

The FDA Law Blog

By Kalie E. Richardson — On October 6, President Joe Biden issued a brief but sweeping three-step statement towards reforming Federal marijuana law.

Sales 87
article thumbnail

Provention and Sanofi enter deal to launch teplizumab for type 1 diabetes

Pharmaceutical Technology

Provention Bio and Sanofi US have signed a co-promotion agreement to launch the former’s lead investigational drug candidate, teplizumab for the delay in the onset of clinical type 1 diabetes (T1D).

article thumbnail

Prime Medicine raises $175M in one of the year’s largest biotech IPOs

Bio Pharma Dive

The gene editing startup is one of less than two dozen biotech companies to debut on Wall Street this year, as the pace of IPOs remains far off last year’s trajectory

article thumbnail

Bayer launches new LifeHub in Monheim concentrated on the Future of Agriculture in Europe

The Pharma Data

article thumbnail

AcuraBio Appoints Talented Senior Executives to Drive Global Growth Program

Pharma Mirror

BRISBANE, AUS, AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, recently acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners, announced today new senior executive hires to support global growth plans.

HR 130
article thumbnail

Positive in vitro results for Imutex’s FLU-v

Pharma Times

Data further supports the continued development of FLU-v as a broad-spectrum influenza vaccine

In-Vitro 127
article thumbnail

Biogen agrees to pay $900 million in largest FCA Settlement Ever Secured without Government’s Intervention

The FDA Law Blog

By Faraz Siddiqui & Jeffrey N. Wasserstein — On September 26, 2022, Biogen Inc. agreed to pay $900 million to the United States and various states to settle a False Claims Act (FCA) lawsuit. This lawsuit was brought to the U.S.

Doctors 87
article thumbnail

Merck and Moderna partner to develop and sell cancer vaccine

Pharmaceutical Technology

German pharmaceutical firm Merck has extended its partnership with Moderna to jointly develop and sell mRNA-4157/V940, an investigational personalised cancer vaccine (PCV). In 2016, the companies entered a strategic partnership to develop novel messenger RNA (mRNA) based PCVs.

article thumbnail

A Versant-backed biotech emerges to take on ‘overlooked’ cancer targets

Bio Pharma Dive

Nested Therapeutics touts a deep bench of scientific leaders and advisers, including Kevan Shokat, whose work drugging KRAS — a cancer-related gene once thought to be undruggable — helped lead to the development of Amgen’s Lumakras

Gene 282
article thumbnail

GSK marketing authorisation operation for respiratory syncytial contagion aged adult vaccine seeker accepted by European Medicines Agency under accelerated assessment

The Pharma Data

article thumbnail

Olympus EU-ME3 Ultrasound Processor, Delivers Higher Resolution Images for Endoscopic Ultrasound

Pharma Mirror

TOKYO / HAMBURG, Olympus Corporation (Olympus), a global medtech company committed to making lives healthier, safer and more fulfilling, has announced the launch of the EU-ME3, a new Endoscopic Ultrasound Processor which addresses the needs of healthcare professionals for high-quality clear images while conducting endoscopic ultrasound procedures.

130
130
article thumbnail

‘Junk’ DNA may hold the key to neurological disorders

Pharma Times

University of Lincoln and the University of Sheffield are researching how DNA could be repaired

DNA 127
article thumbnail

The Intricacies of the Pharma Cold Chain

Pharmaceutical Commerce

How to navigate the ongoing temperature challenges surrounding storage & distribution.

83
article thumbnail

Hookipa partners with Roche for cancer immunotherapy development

Pharmaceutical Technology

Hookipa Pharma and Roche have signed a strategic partnership and licence agreement for developing HB-700 and another undisclosed arenaviral immunotherapy. Under the deal, Hookipa will carry out research and initial clinical development through Phase Ib for HB-700 to treat KRAS-mutated cancers.

article thumbnail

AstraZeneca to acquire gene editing biotech LogicBio

Bio Pharma Dive

Shares in LogicBio had lost nearly all their value since a 2018 IPO, bringing the company to the brink of Nasdaq delisting. The buyout deal represents a premium of over 600

article thumbnail

Novel derivative of “love hormone” oxytocin improves cognitive impairment in Alzheimer’s

The Pharma Data

The cognitive decline and memory loss observed in Alzheimer’s complaint( announcement) is attributed to the accumulation of ?- amyloid protein( A?), which impairs neural function in the brain.

article thumbnail

Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022

Pharma Mirror

INCHEON, South Korea, Samsung Biologics (KRX: 207940.KS), a world-leading contract development and manufacturing organization (CDMO), is launching its new proprietary development technology platforms – S-DUAL™ and DEVELOPICK™ – at this year’s BioProcess International Conference and Exhibition in Boston.

article thumbnail

Patient recruitment completed in Tourette syndrome study

Pharma Times

Research has demonstrated a strong safety prolife and reduced tics among participants

Research 125